These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2844067)

  • 21. Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone.
    Liberman UA; Eil C; Holst P; Rosen JF; Marx SJ
    J Clin Endocrinol Metab; 1983 Nov; 57(5):958-62. PubMed ID: 6311866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D metabolism in hypoparathyroidism.
    Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
    Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
    Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
    [No Abstract]   [Full Text] [Related]  

  • 24. Cortisol-dihydrotachysterol antagonism in a patient with hypoparathyroidism and adrenal insufficiency: apparent inhibition of bone resorption.
    Farrell PM; Rikkers H; Moel D
    J Clin Endocrinol Metab; 1976 May; 42(5):953-7. PubMed ID: 1270584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 26. [New viewpoints on the therapy and prevention of renal osteopathy].
    Kaiser W; Mampel E
    Z Gesamte Inn Med; 1977 Jun; 32(12):254-9. PubMed ID: 333796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolites and analogues of vitamin D. Which for what?
    Haussler MR; Cordy PE
    JAMA; 1982 Feb; 247(6):841-4. PubMed ID: 6895767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients.
    Fanti P; Smith AJ; Price PA; Reitz RE; Malluche HH
    J Clin Endocrinol Metab; 1986 May; 62(5):869-73. PubMed ID: 3485651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolism of dihydrotachysterols: renal side chain and non-renal nuclear hydroxylations in vivo and in vitro.
    Qaw F; Schroeder NJ; Calverley MJ; Trafford DJ; Makin HL; Jones G
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):859-70. PubMed ID: 1562563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary hypoparathyroidism resistant to treatment with vitamin D3, 25-hydroxycholecalciferol and dihydrotachysterol. Efficacy of treatment with 1 alpha,25-dihyroxycholecalciferol].
    Sanmartí Sala A; Recas Planellas I; Tresánchez Trías JM; Mesa Manteca J; Bonal Bastons J; Foz Sala M
    Med Clin (Barc); 1983 Apr; 80(12):541-4. PubMed ID: 6306361
    [No Abstract]   [Full Text] [Related]  

  • 31. Distinct target cells and effects of 1 alpha,25-dihydroxyvitamin D3 and glucocorticoids in the rat thymus gland.
    Provvedini DM; Sakagami Y; Manolagas SC
    Endocrinology; 1989 Mar; 124(3):1532-8. PubMed ID: 2537186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites.
    Sömjen D; Weisman Y; Berger E; Earon Y; Kaye AM; Binderman I
    Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D receptors in intestine, kidney and thymus of streptozotocin diabetic rats.
    Stone LA; Weaver VM; Bruns ME; Welsh J
    Diabetes Res; 1990 Dec; 15(4):165-72. PubMed ID: 1966737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
    Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D physiology.
    Lips P
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
    Okano K; Furukawa Y; Morii H; Fujita T
    J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. History and organization of the Growth Failure in Children with Renal Diseases Study.
    Chan JC; McEnery PT; Brouhard BH; Chinchilli VM; Greifer I
    J Pediatr; 1990 Feb; 116(2):S3-7. PubMed ID: 2405133
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypercalcemia-induced renal insufficiency during therapy with dihydrotachysterol.
    Jehle DR; Keller F; Schwarz A; Jehle PM
    J Med; 1999; 30(1-2):39-50. PubMed ID: 10515239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological importance of vitamin D metabolism.
    Haussler MR; Chandler JS; Pike JW; Brumbaugh PF; Speer DP; Pitt MJ
    Prog Biochem Pharmacol; 1980; 17():134-42. PubMed ID: 6259650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.